Clever Leaves to Present at the Benzinga Virtual Cannabis Capital Conference on June 3, 2021
27 Mai 2021 - 2:30PM
Clever Leaves Holdings Inc. (Nasdaq: CLVR) (“Clever Leaves” or the
“Company”), a multinational operator, or MNO, and licensed producer
of pharmaceutical-grade cannabinoids, has been invited to present
at the Benzinga Cannabis Capital Conference, which is being held
virtually from June 3-4, 2021.
Clever Leaves management is scheduled to present on Thursday,
June 3rd at 1:35 p.m. Eastern time, with one-on-one meetings to be
held throughout the conference. The presentation will be webcast
live and available for replay here and via the Events section of
the Company’s website here.
To receive additional information, request an invitation or
schedule a one-on-one meeting with Clever Leaves management, please
contact your Benzinga representative or the Company’s investor
relations team at CLVR@gatewayir.com.
About Clever Leaves Holdings
Inc.
Clever Leaves is a multinational cannabis company with an
emphasis on ecologically sustainable, large-scale cultivation and
pharmaceutical-grade processing as the cornerstones of its global
cannabis business. With operations and investments in the United
States, Canada, Colombia, Germany and Portugal, Clever Leaves has
created an effective distribution network and global footprint,
with a foundation built upon capital efficiency and rapid growth.
Clever Leaves aims to be one of the industry’s leading global
cannabis companies recognized for its principles, people, and
performance while fostering a healthier global community. Clever
Leaves has received multiple international certifications that have
enabled it to increase its export and sales capacity from its
Colombian operations, including European Union Good Manufacturing
Practices (EU GMP) Certification, a Good Manufacturing Practices
(GMP) Certification by Colombia National Food and Drug Surveillance
Institute - Invima, and Good Agricultural and Collecting Practices
(GACP) Certification. Clever Leaves was granted a license in
Portugal from Infarmed – the Portuguese health authority – which
allows Clever Leaves to cultivate, import and export dry flower for
medicinal and research purposes. In addition, the Portuguese
operation was granted certification of compliance with GACP and
IMC-GAP.
For more information, please visit
https://cleverleaves.com/en/home/ and follow us on LinkedIn.
Clever Leaves Investor
Inquiries:Cody Slach and Jackie KeshnerGateway Investor
Relations+1949-574-3860CLVR@gatewayir.com
Clever Leaves Press
Contacts:McKenna MillerKCSA Strategic
Communications+1347-487-6197mmiller@kcsa.com
Diana SigüenzaStrategic Communications
Director+57310-236-8830diana.siguenza@cleverleaves.com
Clever Leaves Commercial
Inquiries:Andrew MillerVice President Sales - EMEA, North
America, and
Asia-Pacific+1416-817-1336andrew.miller@cleverleaves.com
Clever Leaves (NASDAQ:CLVR)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Clever Leaves (NASDAQ:CLVR)
Historical Stock Chart
Von Jul 2023 bis Jul 2024